Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A in Tissue Expander Breast Reconstruction
NCT01591746Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2012
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Botox with Placebo (2 arms). Primary endpoints: Change From Baseline in Average Pain Scores Using a Numeric Pain Intensity Scale and Physical Well-Being Using the BREAST-Q, Reconstruction Module. Started Aug 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01591746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01591746.